Johnson & JohnsonJNJNYSE
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 52% recommend buying.

Consensus Rating
Buy
23 analysts·High coverage
52%
Rating Distribution
Strong Buy
00%
Buy
1252%
Hold
1148%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case
$190.00
-11%
Consensus
$213.14
+0%
Bull Case
$240.00
+13%
Price Range23 analysts
Low
Consensus
High
$190.00
$240.00
Current Target
Current Price
$213.03
Upside to Target
$0.11

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026Bernstein
Johnson & Johnson price target raised to $208 from $193 at Bernstein
Target:$208.00
+1.1%from $205.75
Dec 30, 2025Barclays
Johnson & Johnson (JNJ) PT Raised to $217 at Barclays
Target:$217.00
+4.5%from $207.56
Dec 18, 2025Goldman Sachs
Johnson & Johnson price target raised to $240 from $213 at Goldman Sachs
Target:$240.00
+14.1%from $210.33
Dec 17, 2025RBC Capital
Johnson & Johnson price target raised to $240 from $230 at RBC Capital
Target:$240.00
+14.8%from $209.07
Dec 12, 2025Morgan Stanley
Johnson & Johnson price target raised to $197 from $190 at Morgan Stanley
Target:$197.00
-6.5%from $210.60
Dec 11, 2025RBC Capital
Johnson & Johnson price target raised to $230 from $209 at RBC Capital
Target:$230.00
+11.4%from $206.54
Dec 10, 2025HSBC
Johnson & Johnson price target raised to $240 from $215 at HSBC
Target:$240.00
+20.0%from $199.96
Dec 5, 2025Guggenheim
Johnson & Johnson price target raised to $227 from $206 at Guggenheim
Target:$227.00
+12.1%from $202.48
Dec 2, 2025Barclays
Johnson & Johnson price target raised to $197 from $176 at Barclays
Target:$197.00
-4.1%from $205.34
Oct 22, 2025Johnson Rice
Johnson & Johnson downgraded to Hold from Buy at Freedom Capital
Target:$190.00
-1.6%from $193.18
Oct 22, 2025Loop Capital Markets
Freedom Capital Markets Downgrades Johnson & Johnson (JNJ) to Hold
Target:$190.00
-1.6%from $193.18
Oct 15, 2025Argus Research
Johnson & Johnson price target raised to $210 from $185 at Argus
Target:$210.00
+9.8%from $191.19
Oct 15, 2025Raymond James
Johnson & Johnson price target raised to $209 from $174 at Raymond James
Target:$209.00
+9.5%from $190.85
Oct 15, 2025Morgan Stanley
Johnson & Johnson price target raised to $190 from $178 at Morgan Stanley
Target:$190.00
-0.4%from $190.85
Oct 15, 2025Stifel Nicolaus
Johnson & Johnson price target raised to $190 from $165 at Stifel
Target:$190.00
-0.4%from $190.85
Oct 14, 2025UBS
Johnson & Johnson price target raised to $214 from $190 at UBS
Target:$214.00
+14.3%from $187.22
Oct 10, 2025RBC Capital
Johnson & Johnson price target raised to $209 from $185 at RBC Capital
Target:$209.00
+9.3%from $191.29
Oct 6, 2025Bernstein
Johnson & Johnson price target raised to $193 from $172 at Bernstein
Target:$193.00
+2.3%from $188.64
Oct 3, 2025UBS
Johnson & Johnson price target raised to $198 from $175 at BofA
Target:$198.00
+6.5%from $185.98
Oct 3, 2025Wells Fargo
Wells upgrades Johnson & Johnson to Overweight on reduced concerns
Target:$212.00
+14.0%from $185.98
Apr 14, 2025Raymond James
Johnson & Johnson price target lowered to $162 from $165 at Raymond James
Target:$162.00
+4.9%from $154.36
Feb 3, 2025Guggenheim
Johnson & Johnson price target raised to $166 from $162 at Guggenheim
Target:$166.00
+9.3%from $151.87
Oct 16, 2024Goldman Sachs
Johnson & Johnson price target lowered to $159 from $162 at Goldman Sachs
Target:$159.00
-3.2%from $164.28
Oct 16, 2024Morgan Stanley
Johnson & Johnson price target raised to $175 from $169 at Morgan Stanley
Target:$175.00
+6.6%from $164.10
Oct 16, 2024RBC Capital
Johnson & Johnson (JNJ) PT Raised to $181 at RBC Capital
Target:$181.00
+10.3%from $164.10